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Background: Arecoline, a major alkaloid in Areca nut has the ability to induce oxidative stress. The effect of Areca
nut, arecoline on reducing sperm quality and quantity were documented previously using several animal models.
Junction disruption by down-regulation of the junction-adhesive protein via oxidative stress is an important route
mediating abnormal spermatogenesis. Therefore, in this present study, we investigated the functional role of areco-
line on junctional proteins.
Results: To analyze direct effects of arecoline on testis cells, confluent mouse testicular Sertoli cell line TM4 was
exposed to arecoline. Arecoline decreased insoluble zonula occludens-1 (ZO-1) protein expression in TM4 cells,
however, arecoline treatment increased TNF-alpha production in both TM4 and monocytic THP1 cells. In addition,
ERK1/2 inhibitor PD98059 reversed arecoline effects on TNF-alpha and ZO-1.
Conclusions: Arecoline increases the production of TNF-alpha and induces protein redistribution of ZO-1. All these
results explain the role of arecoline in male reproductive dysfunction, besides its cytotoxic induction.
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Betel quid chewing is prevalent among Asian popula-
tions and migrant Asian communities, with about 600
million users reported worldwide [1]. Along with to-
bacco or alcohol consumption, betel quid chewing ranks
as a common addiction [2]. Areca nut in betel quid
has been recognized as a Group I carcinogen to humans
by the International Agency for Research on Cancer
(IARC), World Health Organization [3]. Research on
chemical constituents identified arecoline, arecaidine,
guvacoline and guvacine as its chief alkaloids, arecoline
as most abundant and active [4]. Numerous works dem-
onstrated its mutagenicity, genotoxicity and cytotoxicity
using various experimental models [5,6]. Oxidative stress
has been proven to act as a central role in cell death,* Correspondence: ycko0406@gmail.com
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unless otherwise stated.gene regulation, and inflammatory processes via areco-
line [7,8].
Apart from this, epidemic and experimental studies
have shown that betel quid chewing or areca nut con-
tents displayed harmful effecs for reproductive function.
We and others showed that, betel quid chewing during
pregnancy had a significant effect on birth outcomes:
e.g., sex ratio at birth, lower birth weight, reduced birth
length [9,10]. Exposure of Swiss albino mice to betel
quid displayed embryotoxicity [11]. In addition, areco-
line exposure induced micronuclei and cytokinesis in
Chinese hamster ovary cells [12]. Both areca nut and
arecoline induced male reproductive toxicity by in vitro
or in vivo animal models: e.g., inhibition of male sexual
behavior, abnormal sperm head shape, reduced sperm
count and motility [13-17]. All these findings support a
hypothesis of areca nut’s toxic effect on human repro-
ductive functions. Focusing on male reproductive func-
tion, we primarily concluded that such dysfunction via
areca nut might emanate from reduction in quantity andd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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a pivotal question arose about how areca nut affects sperm.
While our study indicated that, areca nut administration
generated reactive oxygen species (ROS)-related oxidative
stress in rat testis [16], current evidence is still limited, thus
meriting research on direct molecular mechanism(s) of
areca nut or arecoline in male reproductive regulation.
In testis, blood-testis barrier (BTB) and seminiferous
tubules, is an essential microenvironment for spermato-
genesis [18]. Disruption of BTB junction integrity is one
major issue in studying molecular mechanisms of male
reproductive dysfunction via toxicants (Adjudin, Aspirin,
Bisphenol A, Cadmium, etc.) [19]. Previous studies on their
molecular mechanisms have indicated that oxidative stress
is commonly induced in testis via phosphatidylinositol 3-
kinase (PI3K) or mitogen-activated protein kinase (MAPK)
signaling pathways [19,20]. These signaling pathway
up-regulates c-Src kinase activity or production of pro-
inflammatory cytokines (TNF-alpha, TGF-beta2, IL-6, etc.),
which further distorts junction integrity by decreasing or
redistributing junction proteins and subsequently damage
sperm counts. Tight junctions between adjacent Sertoli
cells and epididymal epithelia in testis are critical junction
types in BTB formation. Zonula occludens (ZO-1), a
member of the membrane-associated guanylate kinase
(MAGUK) homologue protein family, is a tight junction
protein [21]. ZO-1 has been reported as a target protein of
several toxicants in BTB disruption [22,23].
This study investigated the molecular mechanism (s)
by how arecoline adversely affects male reproduction.
Using a mouse testis cell line TM4, effects of arecoline
on reproductive gene expressions or signaling activation
were examined. We further investigated the effect of
arecoline on inducing TNF-alpha production and ZO-1
protein redistribution. Our study unearths clues for pos-
sible mechanisms of male reproductive dysfunction by
areca nut or arecoline.
Methods
Cell culture and viability assay
TM4 (mouse testicular Sertoli) and THP1 (human mono-
cytic leukemia) cells purchased from Bioresource Collection
and Research Center (BCRC, Taipei, Taiwan) were main-
tained in DMEM and RPMI 1640 medium, supplemented
with 10% fetal bovine serum at 37°C in a 5% CO2 incuba-
tor. For measurement of cell viability, CytoTox-ONE™
Homogeneous Membrane Integrity Assay (LDH activity)
and CellTiter 96 Aqueous One Solution Cell Proliferation
Assay (MTS Assay) were performed according to manufac-
turer’s protocol (Promega Corporation, Madison, WI).
Reagents and antibodies
Arecoline hydrobromide purchased from Sigma-Aldrich
(St. Louis, MO) used primary antibodies for Western blot:anti-Phospho-Erk1/2 (Thr202/Tyr204) (Millipore, Temecula,
CA), anti-Erk1/2 (Cell Signaling Technology, Danvers,
MA), anti-Phospho-JNK (Millipore Corp., Billerica, MA),
anti-Phospho-IkappaB-alpha (abcam, Cambridge, UK),
anti-PP2A (abcam, Cambridge, UK), anti-Phospho-STAT-1
(Millipore Corp., Billerica, MA), anti-ZO-1 (Invitrogen Cor-
poration, Carlsbad, CA) and anti-GAPDH (GeneTex Inc.,
Hsinchu City, Taiwan). ERK1/2 MAPK inhibitor PD98059
was purchased from Calbiochem (San Diego, CA).
Micro-Western Array analysis
Confluent TM4 cells were treated 400 μM arecoline for
10 or 60 minutes. Micro-Western arrays were performed
to detect the protein phosphorylation or expression by the
Micro-Western Array core facility of National Health Re-
search Institutes (NHRI, Miaoli County, Taiwan). Used 48
antibodies are listed in Additional file 1: Table S1. The
methods were described previously [24,25].
Western blotting analysis
To detect phosphorylated proteins, cells lysates were pre-
pared in lysis buffer A (50 mM Tris–HCl, pH 7.4,
100 mM NaCl, 1 mM EDTA, 10 mM magnesium acetate,
1% NP-40) containing a cocktail of protease inhibitors
(Roche, Mannheim, Germany). Total protein (100 μg) was
separated by SDS-polyacryamide gel and electrotrans-
ferred to polyvinylidene fluoride membranes (Millipore,
Billerica, MA). Membranes were incubated with primary
antibodies as indicated and peroxidase-conjugated sec-
ondary antibodies, protein signals detected by enhanced
chemiluminescence reagent (Millipore, Billerica, MA). For
detection of ZO-1, cells were lysed in lysis buffer B
(50 mM Tris–HCl, pH 7.4, 100 mM NaCl, 1 mM EDTA,
10 mM magnesium acetate, 1.0% Triton X-100, protease
inhibitors cocktail, and 1 mM PMSF) on ice for 10 mi-
nutes. Extracts were centrifuged at 15600 × g for 5 min at
4°C to sediment the insoluble fraction. The pellet was re-
suspended in lysis buffer B and mixed with an equal
volume of 4 × Laemmli’s sample buffer. Sample loading of
insoluble fraction was normalized by protein concentra-
tion of soluble fraction.
Reverse transcription-polymerase chain reaction and
real-time quantitative polymerase chain reaction (RT-qPCR)
For determination of RNA expression, cells were har-
vested in the indicated time points and treated with TRI-
zol reagent (Invitrogen Corporation, Carlsbad, CA) for
RNA extraction according to the manufacturer’s protocol.
The cDNA templates were obtained by reverse transcrip-
tion of total RNA with random primer and high-capacity
cDNA reverse transcription kit (Applied Biosystems, CA).
The products were then subjected to quantitative real-
time RT-PCR analysis with the specific primer pairs per-
formed by an ABI StepOnePlus™ Real-Time PCR Systems
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Master Mix (Invitrogen Corporation, MD). Primer se-
quences were: (1) mouse TNF-alpha forward primer: 5′-
GACGTGGAAGTGGCAGAAGAG-3′, reverse primer:
5′-TGCCACAAGCAGGAATGAGA-3′ [26]. (2) human
TNF-alpha forward primer: 5′-CAGCCTCTTCTCCTT
CCTGAT-3′, reverse primer: 5′-GCCAGAGGGCTGATT
AGAGA-3′ [27]. (3) mouse ZO-1 forward primer: 5′-GGA
GCTACGCTTGCCACACT-3′, reverse primer: 5′-GGTCA
ATCAGGACAGAAACACAGT-3′ [28]. (4) mouse GAPDH
forward primer: 5′-TCTCCCTCACAATTTCCATCCC
AG-3′, reverse primer: 5′-GGGTGCAGCGAACTTTA
TTGATGG-3′ [26]. (5) human GAPDH forward primer:
5′-AGCCACATCGCTCAGACAC-3′, human GAPDH re-
verse primer: 5′-GCCCAATACGACCAAATCC-3′ [29].
Determination of soluble mouse and human TNF-alpha
For measurement of soluble TNF-alpha in culture medium,
confluent TM4 and THP1 (2 × 106) cells were treated with
indicated concentration of arecoline for 6 hours in six-well
plates in 1.5 mL of culture medium per well. Levels of
mouse and human TNF-alpha in culture medium were
gauged by individual enzyme-linked immunosorbent assay
(ELISA) according to manufacteurer’s protocol (Invitrogen
Corporation, Frederick, MD). 50 μL (TM4 cells) and
100 μL (THP1 cells) of culture medium and was added to
well for those ELISA assay. Sensitivity of mouse and hu-
man TNF assays were 3 and 1.7 pg/ml respectively. Detec-
tion ranges of two assays were 19.5-1250 (mouse) and
15.6-1000 (human) pg⁄ml. No species cross-reactivity was
observed in both two assays.
Immunofluorescence (IF) detection of ZO-1
To stain for ZO-1, treated cells were fixed in 3.75% formal-
dehyde for 10 min, then blocked with 1% BSA in PBS for
1 hour at room temperature. Slides were incubated with
rabbit antibodies against ZO-1 (1:100 dilution) for 1 hour,
followed by fluorescein-conjugated anti-rabbit antibody
(Jackson ImmunoResearch Laboratories, Inc., West Grove,
PA) (1:200 dilution) for 1 hour. Between incubations, sam-
ples were washed three times for 10 minutes with PBS,
slides viewed by fluorescent microscopy (Axio Observer.
A1, Zess).
Results
Arecoline induces redistribution of ZO-1 directly
Toxicants can induce intracellular junctional instability
by decrease or redistribution of the junctional proteins
between Sertoli and germ or Sertoli and Sertoli cells.
ZO-1 is one of their target proteins. To test whether
arecoline targets on ZO-1 in testis cells, a mouse Sertoli
cell line TM4 is used. TM4 cells were treated with
400 μM of arecoline for 6 hours, direct effect of areco-
line on cell morphology was confirmed by microscopicanalysis. No any cell loss was observed after arecoline
treatment (Figure 1A).
Though cells were more flat and spreaded than
controls, arecoline did not change cell morphology, for-
mation of bubble or death-like morphology. This result
indicated that cytotoxicity might not be a direct effect
via arecoline in confluent TM4 cells. To test ZO-1 in-
hibition via arecoline, ZO-1 proteins were imunostained
and visualized by fluoresce microscope (Figure 1B). The
punctate signal of ZO-1 on plasma membrane was
stained in control cells, stronger signal detected between
adjacent cells. Treated cells showed decreased expres-
sion of ZO-1 protein. Unlike crowded and closed cell
morphology of controls, arecoline-treated cells showed
flattened and loosened cell morphology. It has been re-
ported that association of ZO-1 with Triton-insoluble
fraction (fraction of membrane cytoskeleton) correlates
with junctional integrity [30]. To evaluate effects of arec-
oline on junctional integrity, cells were treated with
400 μM of arecoline for 6 hours and ZO-1 protein in
Triton-(in)soluble fractions was assessed by Western
blot. While level of soluble ZO-1 rose, arecoline signifi-
cantly reduced insoluble ZO-1 (Figure 1C). At arecoline
concentration of 200 and 400 μM, levels of insoluble ZO-
1 fell to 74.7 ± 7.2% and 42.5 ± 10.7%, as compared with
mock control (Figure 1D). Effect of arecoline on ZO-1
mRNA was tested by qRT-PCR. Although level of ZO-1
mRNA in arecoline treated cells seemed to decreased, the
results showed non-significant inhibition of ZO-1 mRNA
by arecoline at 6 hours of treatment (Figure 1E). Taken to-
gether, these results indicate arecoline decreasing mem-
brane expressions of ZO-1 protein in TM4 cells.Arecoline induces changes on phosphorylation of
multiple signaling proteins
Our recent study indicated that ANE induced ROS-related
oxidative stress in the testis [16]. Here, we found arecoline
inhibited ZO-1 membrane expression, thus we speculated
that arecoline may induce decreased junction integrity by a
molecular mechanism similar to other toxicants.
To screen for signaling or proteins modulated by arec-
oline, Micro-Western Array [24,25], a recently developed
high-throughput Western blotting analysis, was used
(Additional file 2: Figure S1). TM4 cells were treated
with 400 μM of arecoline, cell lysates isolated at 10 and
60 minutes for this analysis. We choice 48 antibodies cap-
able of determining proteins involving in reproduction re-
lated signaling transduction (Additional file 1: Table S1).
As shown in Table 1, arecoline increased the protein
expression of phospho-p44/42 MAPKs(ERK1/2) Thr202/
Tyr204, phospho-p38 MAPK Thr180/Tyr182, phospho-
IkappaB-alpha Ser36, phospho-c-Jun Ser63 and phospho-
mTOR Thr2446. It also decreased the protein abundance
Figure 1 Arecoline decreased membrane expression of ZO-1 in confluent TM4 cells. These were treated with indicated arecoline
concentration for 6 hours. (A) Morphology of confluent TM4 treated with (right panel) or without (left panel) 400 μM of arecoline were visualized.
Treated cells (right panel) displayed flat and spread morphology compared to controls (left panel). (B) ZO-1 protein expression detected by
immunofluorescent assay was visualized by fluorescent microscope. Arecoline-treated cells were manifested lower ZO-1 signal than controls.
(C) Insoluble and soluble fractions of cell lysates were prepared for Z0-1 detection by Western blot. (D) Inhibitory effect of arecoline on insoluble
ZO-1 is plotted on bar graph. Signals of insoluble ZO-1 were quantified by densitometry analysis and expressed as average percentage of
respective control cells from three independent experiments to rate arecoline’s inhibitory effect (*P < 0.05 versus 0 μM controls). (E) The amounts
of ZO-1 mRNA were determined using RT-qPCR. Results depict mean ± SD of three independent experiments. *P < 0.05 compared with cells
incubated without arecoline treatment (0 μM).
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phospho-Src Tyr418.
We next confirmed the results of Micro-Western Array
by traditional Western blotting analysis (Figure 2A). Areco-
line induced phosphorylation of ERK1/2 MAPKs and
IkappaB-alpha. It also decreased signal of phospho-PP2A
and STAT1 in TM4 cell. The results of Micro-Western
Array suggest that arecoline induced changes on phos-
phorylation of c-Jun, p38 MAPK, mTOR and Src. ChangesTable 1 Data collection of significant fold-changes for
detected proteins from Micro-Western Array analysis
Arecoline treated time









Phospho-mTOR (Thr2446) 1.16 2.3
Decreased Phospho-PP2A (Tyr307) 0.89 0.68
Phospho-STAT1 (Ser727) 0.6
Phospho-Src (Tyr418) 0.85 0.79
Note: Relative protein abundance was normalized to the average of GAPDH
and actin. A fold change of 1.3 or 0.7 in expression between 0 and 10 minutes
or 0 and 60 minutes groups was used as a cutoff.in these phosphorylated signal were hardly determined per-
haps due to inappropriate conditions or antibodies. It is
well known that c-Jun is a downstream molecule of c-Jun
N-terminal kinase (JNK) pathway [31]. We therefore alter-
nately tried to rate the phosphorylation of JNK. Indeed,
levels of phosphorylated JNK were increased at 10 minutes
after arecoline stimulation in TM4 cells.
Arecoline is reported to induce cytotoxic effects in
various cell lines, which is mentioned as a major cause
of Betel quid chewing-related diseases. To confirm
whether cytotoxiticity is a direct effect by arecoline on
male reproductive dysfunction, cells were treated with
different doses of arecoline for 6 hours and lactate de-
hydrogenase (LDH) assay performed (Figure 2B). After
6 hours of arecoline treatment, LDH activity was slightly
increased, with significantly effect observed at concen-
tration of 400 μM (122.6 ± 7%, p < 0.05) versus mock
control. Differences between other arecoline-treated groups
and mock control were insignificant, indicating that areco-
line caused little damage to cells. We further tested the ef-
fects of arecoline on cell viability by MTS cell viability assay
(Figure 2C). Arecoline treatment did not decrease cell via-
bility in 6 hours and 12 hours. Slight reduction (about 10%)
appeared at 24 hours of treatment, without statistical sig-
nificance between control and arecoline treated groups.
The results imply that cytotoxicity is not a direct effect on
sperm abnormalities via arecoline.
Figure 2 Arecoline activates ERK1/2 MAPKs and increases TNF-alpha production. (A) Protein signal of phospho-ERK1/2, ERK1/2, phospho-JNK,
phospho-IkappaB-alpha, phospho-PP2A, phospho-STAT1 and GAPDH in arecoline (400 μM) treated cells were detected by Western blot. Arecoline
induces phosphorylation of ERK1/2 MAPKs. These same membranes were stripped and re-detected by antibodies of total ERK1/2 and GAPDH. Results
shown represent three independent experiments. (B) (C) No obvious cell death in arecoline-treated TM4 cells treated with indicated arecoline
concentration, cytotoxicity or viability gauged by released LDH activity detection kit after 6 hours (B) or MTS Assay after 6, 12 and 24 hours of
treatment (C). Data express percentage of control cells (*P < 0.05 versus 0 μM control group). (D) (E) Arecoline induced TNF-alpha mRNA (D) and
soluble protein production (E). Cells were treated with indicated concentration of arecoline for 6 hours, levels of TNF-alpha mRNA measured by
RT-qPCR and soluble protein in culture medium measured by ELISA. Results depict mean ± SD of three independent experiments. *P < 0.05 compared
with cells incubated without arecoline treatment (0 μM).
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Toxicants increase proinflammatory cytokine (TNF-alpha)
expression, which mediates disruption of BTB by down-
regulation of cell junction proteins [32]. TNF-alpha and
other proinflammatory cytokines have been reported to
down-regulate or redistribute cell junction proteins (e.g.
occludin, ZO-1 and N-cadherin), which leads to junction
disruption of cells in testis. Hence, TNF-alpha and other
proinflammatory cytokines are important mediator or
stimulator in modulation of male reproductive functions
[33]. It is reported that arecoline stimulation increases
TNF-alpha production in leukemia culture cells [34]. To
ascertain if arecoline stimulation increases TNF-alpha
production, TM4 cells were treated with arecoline for
6 hours and then for expressions of TNF-alpha mRNA
(Figure 2D) and secreted soluble protein (Figure 2E).
Arecoline treatment, induced TNF-alpha mRNA and sol-
uble protein expression in a dose-dependent manner, sig-
nificant induction was observed at 300 μM or 100 μM
concentration respectively. This result indicated that arec-
oline increased TNF-alpha production in TM4 cells.
Arecoline induces TNF-alpha production and ZO-1
redistribution through ERK1/2 activation
ERK1/2 MAPKs signaling pathway has been reported to
play critical role in male reproductive toxicity. Activation
of ERK1/2 MAPKs stimulated by ANE or arecoline has
also been reported previously [35,36]. Therefore, to test
whether arecoline induced ERK1/2 pathway to regulateTNF-alpha and ZO-1, we used PD98059, ERK1/2 spe-
cific inhibitor.
Confluent TM4 cells were pretreated with or without
10 μM of PD98059 for 1 hour and then incubated in the
presence or absence of 400 μM arecoline for 10 minutes.
Apparently, PD98059 inhibited the basal and arecoline in-
creased ERK1/2 phosphorylation (Figure 3A). We next ex-
amined effect of PD98059 pretreatment on TNF-alpha
production and ZO-1 protein expression in cells treated
with arecoline for 6 hours. Level of mRNA and secreted
soluble protein of TNF-alpha did not change significantly
via PD98059 alone, as measured by RT-qPCR (Figure 3B)
and ELISA analysis (Figure 3C). Furthermore, arecoline-
treated cells showed increased TNF-alpha mRNA and
soluble protein, whereas PD98059 treatment prevented
arecoline effect on TNF-alpha expression.
In arecoline-treated cells, protein levels of insoluble ZO-
1 were decreased to 50.2 ± 7.9%, as compared with mock
control (Figure 3D and E). As results shown in Figure 1C,
soluble ZO-1 was increased. PD98059 alone slightly
increased insoluble ZO-1 expression without statistic sig-
nificance. Importantly, PD98059 pretreatment rescued
arecoline-induced changes on insoluble and soluble ZO-1,
suggesting that ERK1/2 suppression could block the effect
via arecoline on ZO-1 redistribution. These results prove
arecoline induced TNF-alpha level and ZO-1 redistribu-
tion through ERK1/2 activation.
Macrophages and monocytes are important sources of
TNF-alpha [37]. Therefore, we further tested the effects of
Figure 3 Activation of ERK1/2 MAPKs is important for TNF-alpha induction and ZO-1 protein redistribution by arecoline in TM4 cells.
(A) PD98059 pretreatment inhibited ERK1/2 activation. Cells were stimulated with or without 400 μM of arecoline for 10 minutes after
pretreatment with 10 μM PD98059 for 1 hour, levels of ERK1/2 and phospho-ERK1/2 determined by Western blot. Results shown represent three
independent experiments. (B) (C) PD98059 pretreatment inhibited arecoline-induced increase in mRNA (B) and soluble protein (C) of TNF-alpha.
Cells were treated with or without arecoline for 6 hours after PD98059 pretreatment. Levels of mRNA and soluble protein of TNF-alpha were
measured by RT-qPCR and ELISA respectively. Results depict mean ± SD of three independent experiments. *P < 0.05 compared with cells
incubated without arecoline treatment (mock control). (D) PD98059 pretreatment rescued arecoline-induced protein redistribution of ZO-1. Levels
of insoluble or soluble ZO-1 were determinate by Western blot. Results represent three independent experiments. (E) Effect of arecoline and
PD98059 on insoluble ZO-1 is plotted on bar graph. Signals were quantified by densitometry analysis and expressed as average percentage of
respective control cells from three independent experiments (*P < 0.05 versus mock controls).
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cytic cell line THP-1. After 6 hours of treatment, arecoline
increased TNF-alpha mRNA expression (Figure 4A) and
soluble protein expression (Figure 4B) in THP1 cells.
Similarly, pretreatment with PD98059 reversed arecoline
effect (Figure 4C and D). All these Results indicated that
ERK1/2 activation may involved in TNF-alpha induction
by arecoline in THP1 cells.
Discussion
During betel chewing, arecoline can diffuse into blood
through buccal mucosa or be absorbed by gastrointestinal
tract [38]. The concentration of arecoline in saliva was re-
ported to reach around 140 μg/ml (about 902.12 μM)
[39]. Arecoline can be detected in blood, placenta [40],
urine [41] or breast milk [42]. However, reports or infor-
mation on the levels of arecoline or other alkaloids in
testis are lacking. Although male reproductive toxicity via
areca nut or arecoline has been observed in several in vivo
studies [13,17], appropriate dose of alkaloids treatment for
in vitro studies is a controversial issue. In vitro studies of
arecoline effects on sperm motility or morphology by
using dosages of 50 to 300 μg/ml (about 322 to 1933 μM)
have been reported previously [14,15]. In this study, we
used 100 to 400 μM of arecoline treatment for investigat-
ing its possible direct or accumulated effect on Sertoli
cells.
Arecoline is cytotoxitic to various cells: e.g., normal
human gingival fibroblasts (HGF) cell etc. [5]. Those areimplicated in initial pathogenesis of areca nut-linked dis-
ease. Arecoline induced ROS production, and leads to
cell cycle arrest, DNA damage and finally causes cell
death. They are critical mediators of arecoline-induced
cytotoxicity. In this present study, we found that, areco-
line increased TNF-alpha and ZO-1 redistribution with-
out inhibiting cell viability. Nevertheless, we did not
ignore cytotoxic effects of arecoline because of short
treatment time. Owing to our results, we speculate that
induction of proinflammatory cytokines and decrease of
junctional integrity are early events of arecoline effect
on BTB damage before cytotoxicity.
In this study, we used Micro-Western Arrays to detect
which signaling molecules activated after arecoline stimula-
tion. Micro-Western Array, a newly developed assay for
proteomic analysis, is modified from reverse phase protein
array [43]. It is more precise than common dot blot or anti-
body array and suitable for detection of protein abundance
or modification status. Studies on anti-cancer activity of
triol and EGF receptor signaling employed this method
[24,44]. The MAPKs signaling is not only a stress-
responsive signaling, but it is also known to regulate mul-
tiple processes of male reproduction [45]. In maintenance
of BTB junctional integrity, activation of ERK1/2 leads to
restructure BTB, disrupting BTB [46] and germ cell adhe-
sion [47,48]. Our results showed arecoline inducing activa-
tion of ERK1/2 MAPKs in TM4 cells; while expecting, this
result is crucial. Numerous environmental toxicants cause
male reproductive dysfunction through ERK1/2 MAPK
Figure 4 ERK1/2 MAPKs are involved in increases of mRNA and soluble protein TNF-alpha by arecoline in THP1 cells. (A) (B) Arecoline
increased mRNA (A) and soluble protein (B) of TNF-alpha. THP1 (2 × 106 in 1.5 mL) cells were treated with indicated doses of arecoline for 6 hours.
(C) (D) PD98059 inhibited TNF-alpha mRNA (C) and soluble protein (D) inductioin via arecoline. Cells were pretreated with 10 μM PD98059 for 1 h and
further treated with 400 μM arecoline for 6 hours. Those mRNA and soluble protein of TNF-alpha levels were measured by RT-qPCR and ELISA. These
results represent mean ± SD of three independent experiments; asterisk shows significant difference (p < 0.05) compared with controls (0 μM).
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effects as other toxicants. Previous related studies indicate
that exposure to environmental toxicants activates MAPKs
(ERK and JNK/p38) and then induces proinflammatory cy-
tokines (TGF-beta, TNF-alpha, or IL-6) via oxidative stress
[50-52]. Cytokines and activated MAPKs together result in
internalization of tight and adherens junction proteins me-
diated by protein redistribution and endocytic vesicle
[20,53]. Besides this, cytokine induction also stimulates
cells to activate MAPKs signaling, which further amplifies
toxic effects. Those effects could be blocked by specific
inhibitors of MAPKs, confirmed the regulated role of
MAPKs activation [19,20].
Our results of Western blotting also indicated an in-
crease on JNK phosphorylation via arecoline stimulation.
Cadmium, a well known toxicant, has been shown to
induce TGF-beta production and redistribution of tight
junction proteins through p38 and JNK MAPKs path-
ways in rat testis or rat culture cells [23]. Inhibition of
JNK signaling suppressed induction of connective tissue
growth factor in buccal mucosal fibroblasts [54] or
hemeoxygenase-1 in vein endothelial cells via arecoline
[55]. Although our data indicated ERK1/2 inhibitor cause
abolition of arecoline effects on TNF-alpha and ZO-1, we
do not rule out the regulated role of JNK signaling in arec-
oline’s action. TNF-alpha secreted by sertoli and germ
cells during spermatogenesis [52] or macrophages and
monocytes stimulated by environmental toxicants hasbeen proven to disrupt the BTB. TNF-alpha, a pleiotropic
cytokine in testis, induces apoptosis of germ cells during
spermatogenesis [18]. In addition to cause redistribution
of junction proteins directly, changes in levels of testos-
terone were shown in TNF-alpha treated Leydig cells or
TNF-alpha knock out mice [56,57]. Because testosterone
is essential hormone for maintance of steroidogenesis,
testosterone production might be involved in the in vivo
effects of arecoline on male inferitility. Indeed, increased
testotsterone levels and activity of related biosysthsis-
enzyme has been shown in arecoline treated rats [58].
Abnormality on testosterone production might be another
important pathway for arecoline’s effect.
ZO-1 is a well-known tight junction protein and
important marker for integrating tight junction [59]. It
usually binds to actin cytoplasmic filaments and another
tight junction protein- occludin that are down-regulated
in highly invasive cancer cells [60]. It is well known
that dissociation of ZO-1 from the junctional complex is
followed with increased permeability [61]. Our results in-
dicated that arecoline decreases insoluble ZO-1 and in-
creases soluble ZO-1, which represents redistribution of
ZO-1 caused by arecoline. Since ZO-1 functions with
other membrane junctional proteins, reduction of insol-
uble ZO-1 also represents decreased binding of ZO-1 to
cytoskeleton, adherens junctions, or polarity complexes.
Association of ZO-1 with Triton-insoluble fraction
(fraction of membrane cytoskeleton) correlating with
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[30]. Otherwise, our preliminary results also indicated
inhibitory effect on membrane expression of occludin
via arecoline in TM4 cells (Additional file 3: Figure S2A
and B). Nonetheless, arecoline might inhibit occludin
through other pathways since PD98059 could not sta-
bled rescue occludin inhibition via arecoline (Additional
file 3: Figure S2C and D). Although reduced expression
and disrupted distribution of ZO-1 in arecoline-mediated
oral carcinogenesis has been cited by Giri et al.’s, two dif-
ferent observations were shown in our study [62]. Firstly,
our data indicated protein redistribution of ZO-1 was the
primarily effect of arecoline. Second, we found that areco-
line’s effect was through ERK1/2 activation. Importantly,
we found arecoline inducing cellular protein redistribution
of ZO-1 in TM4 sertoli cells, which was an important clue
in molecular mechanisms of male reproductive dysfunc-
tion via areca nut. Arecoline reportedly can cross the
blood brain barrier (BBB) [63]. The BTB, like BBB, also
serves as an immunological barrier to protect meiotic
division and post-meiotic germ cell development from
threats via systemic circulation [18]. This study showed
that arecoline induced ERK1/2 signaling, TNF-alpha pro-
duction, and suppression of ZO-1 membrane expression,
which correspond to mechanisms of BTB disruption via
environmental toxins or drugs. Cytotoxicity of arecoline
might amplify disruptive effect on BTB. Damage to BTB
triggers loss of germ cell and decreased sperm quality or
quantity, thereby causing male reproductive dysfunction.
Conclusions
In conclusion, our study demonstrated ZO-1 redistribution
and TNF-alpha induction by arecoline in TM4 cell. We also
observed arecoline increased of TNF-alpha in THP1 cells.
ERK1/2 MAPKs participates in those effects. Results imply
reduced junctional integrity as early events of reproductive
inhibition via arecoline before cytotoxicity.
Additional files
Additional file 1: Table S1. List of antibodies used for Micro-Western
Array analysis. Briefly information of used antibodies was shown. For data
calculation, protein signals from actin and GAPDH were used as loading
controls.
Additional file 2: Figure S1. Analysis of protein expression in TM4 cells
treated with arecoline by Micro-Western Array assay. Confluent cells
(indicated as minute 0) were treated with 400 μM of arecoline for 10 or
60 minutes, and cell lysates were collected as previously described [23].
Changes in abundance of indicated proteins or their phosphorylated
forms were determined by Micro-Western Array. Here, used 48 antibodies
are listed in Additional file 1: Table S1. As shown in this figure, right half
of blot (well A7-H12) was the duplicate of the left half (well A1-H6). Six
samples printed in each well (from left to right) were cells treated with
arecoline for 0, 10, 60 minutes (1-3) and condition controls (4-6), respectively.
Artificial coloring differentiates the used secondary antibodies in species
(red and green for anti-rabbit and anti-mouse, respectively). Selected data of
relative protein abundance are listed in Table 1.Additional file 3: Figure S2. ERK1/2 inhibitor did not fully rescue
protein redistribution of occludin via arecoline in TM4 cells. Treated
methods are same as Figure 3. (A) (C) Detection of occludin in insoluble
and soluble fractions of cell lysates by Western blot. Results represent
three independent experiments. (B) (D) Effect of arecoline or PD98059 on
insoluble occludin is plotted on bar graph. Insoluble occludin signals
were quantified by densitometry analysis and expressed as average
percentage of respective control cells from three independent
experiments to rate arecoline’s effect (*P<0.05 versus 0 μM controls).
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